510(k) Report

510(k) · Cleared

Cleared

Neonatal Phototherapy System

K200031510(k) TraditionalCleared Oct 5, 2020272-day reviewClass II21 CFR 880.5700

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Avalon Biomedical (Shenzhen) Limited · LBI Unit, Neonatal Phototherapy

Cleared on Oct 5, 2020 as substantially equivalent to K070180 (Respironics Inc., Sleep & Home Respiratory Group, 2007) after a 272-day review. Its family tree reaches back 4 generations to 1994.

Decided
Oct 5, 2020
Review
272 days
Class
Class II
Product code
LBI
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K940996 (1994). 7 ancestors in all, the oldest K883779 (1988). No later device cites it as a predicate yet.

  1. Root · 4 generations backK940996 Olympic Bili-LiteOlympic Medical Corp. · 1994
  2. 3 generations backK022196 Natus Blue Light Phototherapy UnitNatus Medical, Inc. · 2002 · Recalled
  3. 2 generations backK051869 Neoblue Cozy Led Phototherapy SystemNatus Medical, Inc. · 2005
  4. 1 generation backK070180 Wallaby 4Respironics Inc., Sleep & Home Respiratory Group · 2007
  5. This deviceK200031 Neonatal Phototherapy SystemAvalon Biomedical (Shenzhen) Limited · 2020
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K940996Olympic Bili-LiteOlympic Medical Corp.1994—
−3K022196Natus Blue Light Phototherapy UnitNatus Medical, Inc.20025
−2K051869Neoblue Cozy Led Phototherapy SystemNatus Medical, Inc.2005—
−1K070180Wallaby 4Respironics Inc., Sleep & Home Respiratory Group2007—
0 (this device)K200031Neonatal Phototherapy SystemAvalon Biomedical (Shenzhen) Limited2020—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198810
199610
199910
FIG. 1 — Lineage of K200031, 1994–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LBI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LBI device

  1. #1 K251308 SnugLit (TM) Wearable Phototherapy System…score 11.6 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K070180Wallaby 4
Summary page 4
…ame: Neonatal phototherapy unit Device Class: Ⅱ Product Code: LBI Panel: General Hospital Regulation Number: 21 CFR 880.5700 3. Predicate Device: 510(k) Number: K070180 Device Name and Model: Bili-Tx Manufacturer Name: Respironics Inc. 5-1 === P…
Respironics Inc., Sleep & Home Respiratory Group2007—

Also cleared against K070180: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 4 companies; a new generation was cleared every 8.0 years on median.
  • 1 of the 7 ancestors has a recall of any class.
  • 3 other devices also cite its predicate K070180.

How does its category compare?

All LBI devices

LBI Unit, Neonatal Phototherapy: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · LBI

1in 2025

2007: 32009: 22010: 12011: 32012: 52014: 12015: 12016: 32017: 22018: 22019: 12020: 12021: 12025: 12026 (partial year): 1
2007high 5 (2012) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LBI

134in 2016

2007: 91 days median2011: 157 days median2012: 108 days median2016: 134 days median
2007high 157 (2011) · low 91 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LBI

1in 2019

2009: 12014: 12015: 12016: 22019: 1
2007high 2 (2016) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LBI

3in 2025

2007: 12008: 42009: 42010: 92011: 52012: 32013: 62014: 52015: 62016: 222017: 5772018: 372019: 62020: 62021: 22022: 82024: 62025: 3
2007high 577 (2017) · low 0 (2023)2025

MAUDE reports naming product code LBI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200739101
20080—04
20092—14
20101—09
2011315705
2012510803
20130—06
20141—15
20151—16
20163134222
20172—0577
20182—037
20191—16
20201—06
20211—02
20220—08
20230—00
20240—06
20251—03
20261—0—

What is it indicated for?

The Neonatal Phototherapy System, Model: KANGALITE is intended for the treatment of unconjugated hyperbilirubinemia in the population of neonates: gestational age >38 weeks and weight within 2500-4500 grams. It can be used in the clinical setting or in the home environment. It should be used for neonates whom phototherapy has been prescribed. Contraindication The Neonatal Phototherapy System, Model: KANGALITE should NOT be used in cases of: (a)…

Read the full statement (109 words)

The Neonatal Phototherapy System, Model: KANGALITE is intended for the treatment of unconjugated hyperbilirubinemia in the population of neonates: gestational age >38 weeks and weight within 2500-4500 grams. It can be used in the clinical setting or in the home environment. It should be used for neonates whom phototherapy has been prescribed.

Contraindication

The Neonatal Phototherapy System, Model: KANGALITE should NOT be used in cases of:

(a) Congenital porphyria or a family history of porphyria

(b) Concomitant use of drugs or agents that are photosensitizers

A use that does not take into account these contraindications may lead to an ineffective treatment or to potential risks to the patient’s health.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K200031: Neonatal Phototherapy System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K200031

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026